Cargando…
Recommendations on the management of adult patients with rheumatic diseases in the context of SARS-CoV-2/COVID-19 infection. Colombian Association of Rheumatology()
OBJECTIVE: To produce recommendations for patients with rheumatological diseases receiving immunomodulatory and immunosuppressive therapies (conventional drugs, biologicals, and small molecules) during the COVID-19 pandemic. MATERIALS AND METHODS: The recommendations were determined using the Delphi...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7546262/ http://dx.doi.org/10.1016/j.reumae.2020.06.006 |
_version_ | 1783592195267231744 |
---|---|
author | Saldarriaga Rivera, Lina María Fernández Ávila, Daniel Molano, Wilson Bautista Jaramillo Arroyave, Daniel Ramírez, Alain Jasaf Bautista Díaz Maldonado, Adriana Izquierdo, Jorge Hernán Jáuregui, Edwin Latorre Muñoz, María Constanza Restrepo, Juan Pablo Segura Charry, Juan Sebastián |
author_facet | Saldarriaga Rivera, Lina María Fernández Ávila, Daniel Molano, Wilson Bautista Jaramillo Arroyave, Daniel Ramírez, Alain Jasaf Bautista Díaz Maldonado, Adriana Izquierdo, Jorge Hernán Jáuregui, Edwin Latorre Muñoz, María Constanza Restrepo, Juan Pablo Segura Charry, Juan Sebastián |
author_sort | Saldarriaga Rivera, Lina María |
collection | PubMed |
description | OBJECTIVE: To produce recommendations for patients with rheumatological diseases receiving immunomodulatory and immunosuppressive therapies (conventional drugs, biologicals, and small molecules) during the COVID-19 pandemic. MATERIALS AND METHODS: The recommendations were determined using the Delphi method as an agreement tool. A panel of experts was formed, with academic backgrounds and research experience in rheumatology. A literature search was conducted and 42 questions were generated. The level of agreement was made with 80% of approval by the participants. RESULTS: A group of eleven rheumatologists from 7 cities in the country participated. The response rate was 100% for the three consultation rounds. In the first round, agreement was reached on 35 questions, on 37 in the second round, and on 42 questions in the third round. CONCLUSION: The recommendation for the majority of the pharmacological treatments used in rheumatology is to continue with immunomodulatory or immunosuppressive therapies in patients who do not have the infection, and to suspend it in patients with a diagnosis of SARS-CoV-2/COVID-19. |
format | Online Article Text |
id | pubmed-7546262 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología. |
record_format | MEDLINE/PubMed |
spelling | pubmed-75462622020-10-13 Recommendations on the management of adult patients with rheumatic diseases in the context of SARS-CoV-2/COVID-19 infection. Colombian Association of Rheumatology() Saldarriaga Rivera, Lina María Fernández Ávila, Daniel Molano, Wilson Bautista Jaramillo Arroyave, Daniel Ramírez, Alain Jasaf Bautista Díaz Maldonado, Adriana Izquierdo, Jorge Hernán Jáuregui, Edwin Latorre Muñoz, María Constanza Restrepo, Juan Pablo Segura Charry, Juan Sebastián Reumatologi´a Clinica Special Article OBJECTIVE: To produce recommendations for patients with rheumatological diseases receiving immunomodulatory and immunosuppressive therapies (conventional drugs, biologicals, and small molecules) during the COVID-19 pandemic. MATERIALS AND METHODS: The recommendations were determined using the Delphi method as an agreement tool. A panel of experts was formed, with academic backgrounds and research experience in rheumatology. A literature search was conducted and 42 questions were generated. The level of agreement was made with 80% of approval by the participants. RESULTS: A group of eleven rheumatologists from 7 cities in the country participated. The response rate was 100% for the three consultation rounds. In the first round, agreement was reached on 35 questions, on 37 in the second round, and on 42 questions in the third round. CONCLUSION: The recommendation for the majority of the pharmacological treatments used in rheumatology is to continue with immunomodulatory or immunosuppressive therapies in patients who do not have the infection, and to suspend it in patients with a diagnosis of SARS-CoV-2/COVID-19. Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología. 2020 2020-10-09 /pmc/articles/PMC7546262/ http://dx.doi.org/10.1016/j.reumae.2020.06.006 Text en © 2020 Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Special Article Saldarriaga Rivera, Lina María Fernández Ávila, Daniel Molano, Wilson Bautista Jaramillo Arroyave, Daniel Ramírez, Alain Jasaf Bautista Díaz Maldonado, Adriana Izquierdo, Jorge Hernán Jáuregui, Edwin Latorre Muñoz, María Constanza Restrepo, Juan Pablo Segura Charry, Juan Sebastián Recommendations on the management of adult patients with rheumatic diseases in the context of SARS-CoV-2/COVID-19 infection. Colombian Association of Rheumatology() |
title | Recommendations on the management of adult patients with rheumatic diseases in the context of SARS-CoV-2/COVID-19 infection. Colombian Association of Rheumatology() |
title_full | Recommendations on the management of adult patients with rheumatic diseases in the context of SARS-CoV-2/COVID-19 infection. Colombian Association of Rheumatology() |
title_fullStr | Recommendations on the management of adult patients with rheumatic diseases in the context of SARS-CoV-2/COVID-19 infection. Colombian Association of Rheumatology() |
title_full_unstemmed | Recommendations on the management of adult patients with rheumatic diseases in the context of SARS-CoV-2/COVID-19 infection. Colombian Association of Rheumatology() |
title_short | Recommendations on the management of adult patients with rheumatic diseases in the context of SARS-CoV-2/COVID-19 infection. Colombian Association of Rheumatology() |
title_sort | recommendations on the management of adult patients with rheumatic diseases in the context of sars-cov-2/covid-19 infection. colombian association of rheumatology() |
topic | Special Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7546262/ http://dx.doi.org/10.1016/j.reumae.2020.06.006 |
work_keys_str_mv | AT saldarriagariveralinamaria recommendationsonthemanagementofadultpatientswithrheumaticdiseasesinthecontextofsarscov2covid19infectioncolombianassociationofrheumatology AT fernandezaviladaniel recommendationsonthemanagementofadultpatientswithrheumaticdiseasesinthecontextofsarscov2covid19infectioncolombianassociationofrheumatology AT molanowilsonbautista recommendationsonthemanagementofadultpatientswithrheumaticdiseasesinthecontextofsarscov2covid19infectioncolombianassociationofrheumatology AT jaramilloarroyavedaniel recommendationsonthemanagementofadultpatientswithrheumaticdiseasesinthecontextofsarscov2covid19infectioncolombianassociationofrheumatology AT ramirezalainjasafbautista recommendationsonthemanagementofadultpatientswithrheumaticdiseasesinthecontextofsarscov2covid19infectioncolombianassociationofrheumatology AT diazmaldonadoadriana recommendationsonthemanagementofadultpatientswithrheumaticdiseasesinthecontextofsarscov2covid19infectioncolombianassociationofrheumatology AT izquierdojorgehernan recommendationsonthemanagementofadultpatientswithrheumaticdiseasesinthecontextofsarscov2covid19infectioncolombianassociationofrheumatology AT jaureguiedwin recommendationsonthemanagementofadultpatientswithrheumaticdiseasesinthecontextofsarscov2covid19infectioncolombianassociationofrheumatology AT latorremunozmariaconstanza recommendationsonthemanagementofadultpatientswithrheumaticdiseasesinthecontextofsarscov2covid19infectioncolombianassociationofrheumatology AT restrepojuanpablo recommendationsonthemanagementofadultpatientswithrheumaticdiseasesinthecontextofsarscov2covid19infectioncolombianassociationofrheumatology AT seguracharryjuansebastian recommendationsonthemanagementofadultpatientswithrheumaticdiseasesinthecontextofsarscov2covid19infectioncolombianassociationofrheumatology |